Company Overview of Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc., a biopharmaceutical company, engages in the development and manufacture of adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies. The company was incorporated in 2005 and is based in San Diego, California with a subsidiary location in Lausanne, Switzerland.
5375 Mira Sorrento Place
San Diego, CA 92121
Founded in 2005
Key Executives for Stemedica Cell Technologies, Inc.
Vice Chairman and Chief Executive Officer
Chief Regulatory & Clinical Development Officer
Compensation as of Fiscal Year 2014.
Stemedica Cell Technologies, Inc. Key Developments
Stemedica Cell Technologies Appoints Mahendra Rao to its Scientific and Medical Advisory Board
Apr 8 14
Stemedica Cell Technologies Inc. welcomed to its Scientific and Medical Advisory Board prominent stem cell and regenerative medicine expert Dr. Mahendra Rao, M.D., Ph.D. As a Founding Director of the National Institute of Health (NIH) Center for Regenerative Medicine (CRM), he has built the Center into a world-class organization recognized for its excellence in the clinical translation of stem cell technology, and his expertise will help Stemedica shape its strategy to meet global demand for its stem cell technology.
Stemedica Cell Technologies, Inc. Appoints Craig W. Carlson as Chief Financial Officer, Effective March, 2014
Jan 28 14
Stemedica Cell Technologies, Inc. announced that Craig W. Carlson has been appointed the company's Chief Financial Officer effective March, 2014. Craig Carlson brings 34 years of financial, accounting, investor relations, and operational experience specifically in the biotech and biopharmaceutical industries to his role at Stemedica.
Stephen E. Epstein to Head Scientific & Medical Advisory Board for Stemedica Cell Technologies, Inc.'s Cardiology Division
Mar 4 13
Stemedica Cell Technologies, Inc. announced that cardiologist Stephen E. Epstein, MD, Director of Translational Research of the MedStar Heart Institute, Washington Hospital Center, has accepted the position of Chairman of Stemedica’s Scientific and Medical Advisory Board for the Company’s Cardiology Division. Dr. Epstein served for over 30 years as Chief of the Cardiology Branch of the National Heart, Lung and Blood Institute (NHLBI) in Bethesda, Maryland. Dr. Epstein is currently Vice-Chairman of the Data Safety Management Board (DSMB) for Programs of Excellence in Gene and Cell Therapy for the NHLBI, and had served as Chairman of the DSMB for Specialized Centers for Clinically Oriented Research in Cardiac Dysfunction and Disease until the completion of that NHLBI effort.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|